A bicentric open-label, randomized, two-parallel-group study investigating the impact of combined Lantus�(insulin glargine) and Lyxumia �(lixisenatide) on insulin secretion and gastric emptying in subjects with Type 2 Diabetes Mellitus not adequately cont
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest